

Page 48
Notes:
conferenceseries
.com
Volume 8
Journal of Biotechnology & Biomaterials
ISSN: 2155-952X
Pharma Biotech 2018
December 10-11, 2018
December 10-11, 2018 | Rome, Italy
23
rd
International Conference on
Pharmaceutical Biotechnology
Biography
Hanneke Later-Nijland is an Attorney-at-law at Axon Lawyers, Amsterdam, Netherlands. Moreover, she has been trained as a Pharmacist. Furthermore, she has
completed her PhD in Clinical Pharmacokinetics and is a former Inspector for Clinical Trials and Pharmacovigilance at the Netherlands Inspectorate for Healthcare, IGZ.
She specializes in European and national legal and regulatory issues relating to medicinal products. In her practice, she advises life sciences and healthcare clients and
litigates on a wide range of issues, often with a regulatory focus. Her areas of expertise in the medicinal products field covers marketing authorizations, reimbursement,
compliance, pharmacovigilance and advertising issues. In addition, she also assists clients with product liability issues and IP and regulatory issues in transactions in the
life sciences sector. Furthermore, she is a Lecturer at Leiden University Medical Centre. She regularly publishes on new European legislation and the impact of recent
judgments in the sector.
hanneke.later-nijland@axonlawyers.com